Immunotherapy with dendritic cells directed against tumor antigens shared with normal host cells results in severe autoimmune disease. - Wikidata - wikimedia - TriplyDB

Immunotherapy with dendritic cells directed against tumor antigens shared with normal host cells results in severe autoimmune disease.

Immunotherapy with dendritic cells directed against tumor antigens shared with normal host cells results in severe autoimmune disease.

http://www.wikidata.org/entity/Q36375982

about

Design of universal cancer vaccines using natural tumor vessel-specific antigens (SANTAVAC)Evidence of the extrathymic development of tyrosinase-related protein-2-recognizing CD8+ T cells with low avidity Generation in vitro of B-cell chronic lymphocytic leukaemia-proliferative and specific HLA class-II-restricted cytotoxic T-cell responses using autologous dendritic cells pulsed with tumour cell lysate Label-free cytokine micro- and nano-biosensing towards personalized medicine of systemic inflammatory disorders Identification and characterization of 9D7, a novel human protein overexpressed in renal cell carcinoma.Proteomics in cancer vaccine development.SANTAVAC ™: A Novel Universal Antigen Composition for Developing Cancer Vaccines.Heat-shocked tumor cell lysate-pulsed dendritic cells induce effective anti-tumor immune response in vivo.Future therapeutic targets in rheumatoid arthritis?Progress in cancer vaccines by enhanced self-presentation Remnants of suicidal cells fostering systemic autoaggression. Apoptosis in the origin and maintenance of autoimmunity.Dendritic cell-specific antigen delivery by coronavirus vaccine vectors induces long-lasting protective antiviral and antitumor immunity.Immunotherapy: on the edge between experimental and clinical oncology.Biologic and therapeutic role of HER2 in cancer.Tumor-induced endothelial cell surface heterogeneity directly affects endothelial cell escape from a cell-mediated immune response in vitro.Universal cancer vaccine: an update on the design of cancer vaccines generated from endothelial cells.Tolerogenic dendritic cell therapy for rheumatoid arthritis: where are we now?Vaccines in oncology: background and clinical potential.Cell-based therapy approaches using dying cells: from tumour immunotherapy to transplantation tolerance induction.Generation of dendritic cell-based vaccines for cancer therapy.An autoimmune-mediated strategy for prophylactic breast cancer vaccination.Towards patient-specific tumor antigen selection for vaccination.Genetically modified dendritic cells--a new, promising cancer treatment strategy?Dendritic cell-based vaccines and therapies for cancer.Principles of tumor immunosurveillance and implications for immunotherapy.Cancer immunotherapy: the past, the present and the future.Dendritic cell-based immunotherapy for the treatment of hematological malignancies.Tumor antigens and proteomics from the point of view of the major histocompatibility complex peptides.Immunotherapy exploiting the versatility of dendritic cells.Dendritic cells and their potential therapeutic role in haematological malignancy.Autoimmune mediated regulation of ovarian tumor growth.Linking immune-mediated arterial inflammation and cholesterol-induced atherosclerosis in a transgenic mouse model.MHC-bound antigens and proteomics for novel target discovery.Progress in the development of immunotherapy of cancer using ex vivo-generated dendritic cells expressing multiple tumor antigen epitopes.Broadly expressed tumour-associated proteins as targets for cytotoxic T lymphocyte-based cancer immunotherapy.Immunoprevention of basal cell carcinomas with recombinant hedgehog-interacting protein.Dendritic cells loaded with apoptotic antibody-coated tumor cells provide protective immunity against B-cell lymphoma in vivo Administration route-dependent vaccine efficiency of murine dendritic cells pulsed with antigens.Evaluation of the Effect of the 47 kDa Protein Isolated from Aged Garlic Extract on Dendritic Cells.Cytotoxic T cells induce proliferation of chronic myeloid leukemia stem cells by secreting interferon-γ.

P2860

Q28087470-68F7AB8B-F2FA-4474-BD62-4C9D3C7CE10E Q28360452-D1DE4C03-7DE6-47D3-8A00-95A921FA0DA2 Q28362580-CE112ADF-A77A-4AE0-95C9-2EC542F26B88 Q30368512-8C0FA13B-3908-4CBB-999C-0EE5C7F236B1 Q30790800-6803642E-1462-4428-A50E-916B9C0247C8 Q33215044-F6B67AFC-422D-4C1F-8CD7-6AB0E08BB34B Q33578086-3E9FF3EC-B4C0-415A-A7BB-410ABD113BD7 Q33788255-01BA6985-D9F6-44EF-9F08-BEA96C222445 Q33841419-2DAE877C-1296-4BB2-81E1-C863B592E335 Q33929076-60B49A56-01E0-49A6-8B76-DCBCE0900353 Q34004618-245F061B-DA87-496D-9C0D-A7178C747DD2 Q34128906-84297B60-839F-4749-A5AC-72168A8DDBBE Q34172095-7BB08F35-C405-4D51-9AF0-635887A4CFB7 Q34267775-E1AE4FD8-A669-436D-9E88-ABFB6F31C8D3 Q34329922-77691C87-6607-4FCF-BF93-10CF126B698A Q34338192-10022EE3-2589-478C-84D3-EF83294558B1 Q34338355-44F30721-FA03-4F94-954F-8CC274C2D1E4 Q34439914-0655BB5A-AB85-4D2C-B426-C8E3E35BEF38 Q34560654-794EC2D4-E482-4593-9870-C0369AC6C8BC Q34708252-9D3366F9-B09F-492F-9E56-53CACE8F1F12 Q34985115-E13894CF-526E-4C2A-A110-AC9931EC0EB0 Q35005960-52D8A3E1-E227-49EA-B7A1-4F42FF2C3D8C Q35040829-60C1A602-2899-4242-B68E-A121CADD99BD Q35040857-FDEA6ADF-7878-4E2E-9F30-1F2CE3DB6673 Q35043113-9C667B16-B806-4983-8791-ABE596FB977C Q35083647-CF9A1330-D0F6-483B-991D-0776C8879EB0 Q35127001-B282054A-0661-40BA-AC46-AD3861D0761D Q35160569-958F31B9-E541-41AD-B5C2-E7B2F0F67EC5 Q35201914-E97EC19A-2164-42EE-B027-BF8DE3BE2D5F Q35614625-C93CD411-E48F-46DC-8F2C-F5D7D41B97C3 Q35673346-D6E4AA9A-FEC2-48CB-BFA9-35A0F23E94B2 Q35824235-E6BA2A7F-C1E4-499C-A5BC-0A398E3B7C97 Q35911151-852A5B7C-6C11-4DC7-9091-C7BA2F450025 Q35922431-1BDF4E70-40D8-4AD1-8AB2-5F03EB19A78C Q36239656-344FBAAA-124E-45EE-AE4B-92818FEB913F Q36402362-DF8EFB4F-3F95-45F4-B8EF-6332CD469B29 Q36407174-E7A35AF5-7867-43C9-A697-3C7E6A5DD911 Q36622359-0560FC5E-E75B-483B-A713-AEC7237BD595 Q36652557-47822667-0372-4643-A9C0-422B07B92545 Q36694195-33086007-4F55-4A22-A4CB-D0A7202CBA6E

P2860

Immunotherapy with dendritic cells directed against tumor antigens shared with normal host cells results in severe autoimmune disease.

http://www.wikidata.org/entity/Q36375982

description

2000 nî lūn-bûn

@nan

2000年の論文

@ja

2000年学术文章

@wuu

2000年学术文章

@zh-cn

2000年学术文章

@zh-hans

2000年学术文章

@zh-my

2000年学术文章

@zh-sg

2000年學術文章

@yue

2000年學術文章

@zh

2000年學術文章

@zh-hant

name

Immunotherapy with dendritic c ...... in severe autoimmune disease.

@ast

Immunotherapy with dendritic c ...... in severe autoimmune disease.

@en

type

label

Immunotherapy with dendritic c ...... in severe autoimmune disease.

@ast

Immunotherapy with dendritic c ...... in severe autoimmune disease.

@en

prefLabel

Immunotherapy with dendritic c ...... in severe autoimmune disease.

@ast

Immunotherapy with dendritic c ...... in severe autoimmune disease.

@en

P1433

Q36375982-0EE4A23D-D98A-47B4-A2FB-298E55F15CCA

P1476

Q36375982-4EB41A01-23EF-49DE-BAE2-D2AD011D1E0D

P2093

Q36375982-0B58DA52-DCBE-414B-B140-DED25764B189

Q36375982-1A05A41A-53C1-4014-8FA7-9BE461BD13DA

Q36375982-2F00C2C4-43A0-46FE-AB46-8894E2F3ACC5

Q36375982-6C47A4A6-E158-4D22-A02A-FB729B79B4C0

Q36375982-9603328C-59F0-4B31-AC29-2ADC97AA6D7B

Q36375982-A64F6128-8519-41E8-996B-01C467A31A62

P2860

Q36375982-09170563-6026-4ABA-907C-D917C8D77706

Q36375982-14A30C50-E561-432D-AB03-DED06E818CCC

Q36375982-1CFC31D1-66EE-4546-9A5E-C9B5C678CF30

Q36375982-256736D0-C85E-4189-BCD8-789262C0C198

Q36375982-3413A4CD-6684-4C92-B3CB-5D74E1AAE435

Q36375982-3998C870-F859-4A51-8AB0-030919A1203B

Q36375982-3AA8FE1D-EB04-4DE9-BADB-7268B3B2F0C9

Q36375982-40BAAB7B-A206-4FBC-BF40-4448D5BE4F69

Q36375982-52D66DAD-47A6-485D-AEDF-BE7CD4A80AD0

Q36375982-5439FACE-FBCC-45A7-9CBB-EB1AEE69CA94

P304

Q36375982-8F9836E0-CD0D-48E6-99E7-3FA07905C79F

P31

Q36375982-5085EFC4-1AD2-4731-8526-29526150CB9F

P356

Q36375982-AC3115D8-9DC2-4384-BCBC-561ACE2CD3EB

P407

Q36375982-A15CE3FC-0E45-4B71-ACA5-3F23B14BCBA5

P433

Q36375982-B4215A05-BB08-48CC-A01E-31899B352C6C

P478

Q36375982-F74FEE07-197A-4544-9C8B-603600EA5824

P577

Q36375982-1EA1574D-2533-4315-A0C2-98C33AE6E531

P5875

Q36375982-01ACC3AC-B184-46B0-8A5B-71388A3B7906

P698

Q36375982-7BC9520F-EE23-47B2-84DC-E66BEFBB4E27

P921

Q36375982-3B9C5047-D823-4807-A87A-37CBCE6F80B7

P932

Q36375982-C22ED375-BE88-4555-9009-DCBF5C9777A6

P356

P1433

Journal of Experimental Medicine

P1476

Immunotherapy with dendritic c ...... in severe autoimmune disease.

@en

P2093

Hengartner H

http://www.w3.org/2001/XMLSchema#string

Ludewig B

http://www.w3.org/2001/XMLSchema#string

Ochsenbein AF

http://www.w3.org/2001/XMLSchema#string

Odermatt B

http://www.w3.org/2001/XMLSchema#string

Paulin D

http://www.w3.org/2001/XMLSchema#string

Zinkernagel RM

http://www.w3.org/2001/XMLSchema#string

P2860

Identification of TRP-2 as a human tumor antigen recognized by cytotoxic T lymphocytes

Dendritic cells and the control of immunity

A new era for cancer immunotherapy based on the genes that encode cancer antigens

Regression of small-cell lung carcinoma in patients with paraneoplastic neuronal antibodies

The dendritic cell system and its role in immunogenicity

Dendritic cells efficiently induce protective antiviral immunity.

Vaccination with a recombinant vaccinia virus encoding a "self" antigen induces autoimmune vitiligo and tumor cell destruction in mice: requirement for CD4(+) T lymphocytes.

Induction of antigen-specific T cell anergy: An early event in the course of tumor progression

An evaluation of the potential to use tumor-associated antigens as targets for antitumor T cell therapy using transgenic mice expressing a retroviral tumor antigen in normal lymphoid tissues.

Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines.

P304

795-804

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1084/JEM.191.5.795

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

191

http://www.w3.org/2001/XMLSchema#string

P577

2000-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

12612174

http://www.w3.org/2001/XMLSchema#string

P698

10704461

http://www.w3.org/2001/XMLSchema#string

P921

P932

2195849

http://www.w3.org/2001/XMLSchema#string